ArticleProceedings of the National Academy of Sciences of the United States of America2026
Mutation rate variability in viral populations: Implications for lethal mutagenesis.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mutation rate variability in viral populations: Implications for lethal mutagenesis.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Rethinking viral evolution: How BIAS mechanisms and Gamma-Poisson overdispersion redefine lethal mutagenesis.Frontiers in microbiology · 2026Article
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Lethal mutagenesis is a strategy to achieve viral extinction by drugging viral mutation rates beyond an extinction threshold. Accurate estimation of the extinction threshold is critical, as elevating viral mutation rates near, but not past this threshold increases the likelihood of mutations that could result in drug resistance, vaccine escape, or increased pathogenesis. Traditional models of lethal mutagenesis rely on the Poisson distribution, which assumes a uniform mutation rate across individuals. Yet, RNA viruses like influenza A virus (IAV) can have varied mutation rates due to mutations in the polymerase complex. This variability suggests that lethal mutagenesis models incorporating mutation rate diversity, such as ones using the gamma-Poisson distribution, may be more accurate for RNA viruses. Poisson models assume count data have equal mean and variance, while gamma-Poisson counts are overdispersed (variance greater than mean). Here, we provide experimental data showing that IAV mutations are overdispersed, indicating that the gamma-Poisson distribution is more appropriate for modeling IAV mutations. Modeling of lethal mutagenesis using the gamma-Poisson distribution reveals that the degree of overdispersion is critical in determining survival or extinction. Increased overdispersion shifts the extinction threshold higher, indicating that Poisson-based models have underestimated the mutation rate required to achieve viral extinction and avoid viral escape or accelerated evolution. Furthermore, time to extinction in simulated populations is significantly longer with gamma-Poisson-based models than Poisson-based. This investigation of how mutation rate variability affects lethal mutagenesis will directly impact antiviral drug design and strategy, thus advancing efforts to combat virus outbreaks and future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.